<DOC>
	<DOCNO>NCT00355758</DOCNO>
	<brief_summary>: Researchers would like see new test call SELDI ( Surface Enhanced Laser Desorption Ionization ) analysis predict biopsy result well PSA test .</brief_summary>
	<brief_title>UCI 03-72 Prostate Cancer Detection Serum Proteomic Profiling</brief_title>
	<detailed_description>A blood sample approximately 30 cc collect prior patient standard care radical prostatectomy surgery . This blood use SELDI analysis . The remainder blood sample store may use PSA test later date . The patient final blood draw 3 month 1 year follow surgery .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>For subject : Men 50 year age old . Serum PSA great equal 2.5 ng/ml less equal 10.0 ng/ml determine measurement within past six month , and/or digital rectal exam suspicious prostate cancer determine patient 's Urologist . It determine treat physician prostate biopsy clinically indicate . Patients already diagnosed prostate cancer schedule radical prostatectomy . For study treatment effect Men clinically localize prostate cancer ( total PSA &lt; 20 ng/ml clinical T2b le ) . Men organ confine prostate cancer determine final pathologic diagnosis . Exclusion criteria subject : Known prostate cancer prior treatment prostate cancer . Acute prostatitis . Untreated urinary tract infection . Presence Foley catheter urethral instrumentation previous 48 hour . Hormonal therapy include LHRH agonist , oral antiandrogens , estrogenic compound , Proscar phytotherapy within previous 6 month . Exclusion Criteria ( study treatment effect ) Men nonorgan confine prostate cancer . Men detectable serum PSA level 1 month follow radical prostatectomy .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Prostate Cancer Detection Serum Proteomic Profiling</keyword>
</DOC>